
|Articles|May 13, 2021
App Note: The Chiral Separation of Remdesivir and Several of its Key-Starting Materials
Author(s)Chiral Technologies, Inc.
This application note shares new chiral separations for the anti-viral, COVID-19 treatment Remdesivir and its phosphoramidite and nucleoside key-starting materials.
